Hims & Hers Health Inc (NYSE:HIMS) Share Price

Company Profile

Business description
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Contact
2269 Chestnut Street
No. 523
San FranciscoCA94123
USA
T: +1 415 851-0195
https://www.forhims.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,442

Recommended

Falling electricity prices weigh on earnings outlook for utility provider.

Adrian Atkins | 06 August 2026

This AI beneficiary may still be one of the market’s most compelling bargains.

Tyger Fitzpatrick | 06 August 2026

A closer look at the key earnings results from the first week of August reporting.

Tyger Fitzpatrick | 06 August 2026

Index	Last price	Change	% Change
All Ordinaries	9,452.00	42.10	0.45%
CAC 40	8,736.07	66.78	0.77%
DAX 40	26,196.40	70.10	0.27%
Dow JONES (US)	54,313.22	35.90	-0.07%
FTSE 100	10,873.77	14.53	-0.13%
HKSE	25,530.28	385.54	-1.49%
NASDAQ	26,441.01	77.57	0.29%
Nikkei 225	65,683.26	617.18	-0.93%
NZX 50 Index	13,958.06	39.12	-0.28%
S&P 500	7,738.96	15.41	0.20%
S&P/ASX 200	9,271.60	41.80	0.45%
SSE Composite Index	3,900.35	21.92	0.57%